Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidades: FM, ICB
Subjects: IMUNOLOGIA, EXPRESÃO GÊNICA, COLÁGENO, SISTÊMICO ESCLERODERMA
ABNT
MORAIS, J. et al. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 25 ago. 2024. , 2014APA
Morais, J., Martin, P., Velosa, A. P. P., Andrade, P. C., Cruz, I. B., Miracca, E. C., et al. (2014). Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201NLM
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 ago. 25 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201Vancouver
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 ago. 25 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201